Susquehanna Fundamental Investments’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$44K	Sell	41,574 -1,326	-3%	-$1.4K	﹤0.01%	1496
2021 Q4	$36K	Sell	42,900 -16,600	-28%	-$13.9K	﹤0.01%	1383
2021 Q3	$79K	Sell	59,500 -6,600	-10%	-$8.76K	﹤0.01%	1637
2021 Q2	$126K	Buy	+66,100	New	+$126K	﹤0.01%	1550